BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38141832)

  • 1. BTK signaling-a crucial link in the pathophysiology of chronic spontaneous urticaria.
    Bernstein JA; Maurer M; Saini SS
    J Allergy Clin Immunol; 2024 May; 153(5):1229-1240. PubMed ID: 38141832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenebrutinib in H
    Metz M; Sussman G; Gagnon R; Staubach P; Tanus T; Yang WH; Lim JJ; Clarke HJ; Galanter J; Chinn LW; Chu T; Teterina A; Burgess T; Haddon DJ; Lu TT; Maurer M
    Nat Med; 2021 Nov; 27(11):1961-1969. PubMed ID: 34750553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune chronic spontaneous urticaria.
    Kolkhir P; Muñoz M; Asero R; Ferrer M; Kocatürk E; Metz M; Xiang YK; Maurer M
    J Allergy Clin Immunol; 2022 Jun; 149(6):1819-1831. PubMed ID: 35667749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Responsiveness of Basophils via FcεRI Reflects Disease Activity in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2019; 7(8):2835-2844.e7. PubMed ID: 31136822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions.
    Mendes-Bastos P; Brasileiro A; Kolkhir P; Frischbutter S; Scheffel J; Moñino-Romero S; Maurer M
    Allergy; 2022 Aug; 77(8):2355-2366. PubMed ID: 35175630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease.
    Langrish CL; Bradshaw JM; Francesco MR; Owens TD; Xing Y; Shu J; LaStant J; Bisconte A; Outerbridge C; White SD; Hill RJ; Brameld KA; Goldstein DM; Nunn PA
    J Immunol; 2021 Apr; 206(7):1454-1468. PubMed ID: 33674445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Theories of Chronic Spontaneous Urticaria.
    Bracken SJ; Abraham S; MacLeod AS
    Front Immunol; 2019; 10():627. PubMed ID: 30984191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
    MacGlashan D; Saini S; Schroeder JT
    J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
    Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
    Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
    Johal KJ; Chichester KL; Oliver ET; Devine KC; Bieneman AP; Schroeder JT; MacGlashan DW; Saini SS
    J Allergy Clin Immunol; 2021 Jun; 147(6):2271-2280.e8. PubMed ID: 33713769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive IgE in Chronic Spontaneous/Idiopathic Urticaria and Basophil/Mastocyte Priming Phenomenon, as a Feature of Autoimmune Nature of the Syndrome.
    Panaszek B; Pawłowicz R; Grzegrzółka J; Obojski A
    Arch Immunol Ther Exp (Warsz); 2017 Apr; 65(2):137-143. PubMed ID: 27582030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.
    Alizadeh Aghdam M; Knol EF; van den Elzen M; den Hartog Jager C; van Os-Medendorp H; Knulst AC; Otten HG; Röckmann H
    Clin Exp Allergy; 2020 Mar; 50(3):364-371. PubMed ID: 31925825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.
    Izaki S; Toyoshima S; Endo T; Kanegae K; Nunomura S; Kashiwakura JI; Sasaki-Sakamoto T; Nakamura R; Akiyama H; Ra C; Hayama K; Terui T; Okayama Y
    Allergol Int; 2019 Jul; 68(3):342-351. PubMed ID: 30803853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling chronic spontaneous urticaria pathophysiology through systems biology.
    Segú-Vergés C; Gómez J; Terradas-Montana P; Artigas L; Smeets S; Ferrer M; Savic S
    J Allergy Clin Immunol; 2023 Apr; 151(4):1005-1014. PubMed ID: 36587849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bruton's Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures.
    Ringheim GE; Wampole M; Oberoi K
    Front Immunol; 2021; 12():662223. PubMed ID: 34803999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria.
    Maurer M; Berger W; Giménez-Arnau A; Hayama K; Jain V; Reich A; Haemmerle S; Lheritier K; Walsh P; Xia S; Storim J
    J Allergy Clin Immunol; 2022 Dec; 150(6):1498-1506.e2. PubMed ID: 36096203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
    Larenas-Linnemann D
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):655-664. PubMed ID: 38064133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.
    Kaplan A; Lebwohl M; Giménez-Arnau AM; Hide M; Armstrong AW; Maurer M
    Allergy; 2023 Feb; 78(2):389-401. PubMed ID: 36448493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil Characteristics as a Marker of the Pathogenesis of Chronic Spontaneous Urticaria in Relation to the Coagulation and Complement Systems.
    Yanase Y; Matsubara D; Takahagi S; Tanaka A; Ozawa K; Hide M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.